As shown in Table 2, for the TERT rs2736100 polymorphism, all studies combined (23032 cases and 38274 controls) were pooled into the meta-analysis, and a significantly increased cancer risk was found for all genetic models based on the studies (GG versus TT: OR = 1.72, 95% CI: 1.58, 1.88; GT versus TT: OR = 1.38, 95% CI: 1.29, 1.47; dominant model-TG + GG versus TT: OR = 1.47, 95% CI: 1.37, 1.58; recessive model-GG versus TT + TG: OR = 1.37, 95% CI 1.31, 1.43; additive model-2GG + TG versus 2TT + TG: OR = 1.30, 95% CI: 1.25, 1.36). Here, TERT is linked to cancer.